Patents Examined by John M. Ford
  • Patent number: 6440976
    Abstract: Compounds described by the chemical structural formula or a pharmaceutically acceptable salt thereof, are useful in the treatment of pain, migraine, depression, anxiety, schizophrenia, Parkinson's disease, stroke, and in the treatment of neuropathies including postherpetic neuralgia, central pain from spinal cord injury, and phantom limb pain.
    Type: Grant
    Filed: June 25, 2001
    Date of Patent: August 27, 2002
    Assignee: Merck & Co., Inc.
    Inventors: David A. Claremon, John A. McCauley, Nigel J. Liverton, Cory R. Theberge
  • Patent number: 6440903
    Abstract: The invention relates to novel substituted 2,4-diamino-1,3,5-triazines of the formula (I) (in which R1, R2, R3, X and Z are each as described in the description), to processes and to novel intermediates for their preparation and to their use as herbicides.
    Type: Grant
    Filed: April 1, 1999
    Date of Patent: August 27, 2002
    Assignees: Bayer Aktiengesellschaft, Nihon Bayer Agrochem K.K.
    Inventors: Hans-Jochem Riebel, Stefan Lehr, Uwe Stelzer, Yukiyoshi Watanabe, Markus Dollinger, Seishi Ito, Toshio Goto, Akihiko Yanagi
  • Patent number: 6441170
    Abstract: The present invention relates to a process for preparing 4,6-dichloro-pyrimidine by reaction of 4-chloro-6-methoxypyrimidine with an acid chloride in the presence of a hydrogen halide.
    Type: Grant
    Filed: December 19, 2001
    Date of Patent: August 27, 2002
    Assignee: Bayer Akitnegesellschaft
    Inventors: Franz-Josef Mais, Günther Cramm, Alexander Klausener, Guido Steffan
  • Patent number: 6441171
    Abstract: The invention relates to a method for the preparation of 4,6-dichloropyrimidine by reacting 4-chloro-6-methoxypyrimidine with phosgene as chlorinating agent in the presence of a nitrogen-containing auxiliary.
    Type: Grant
    Filed: January 24, 2002
    Date of Patent: August 27, 2002
    Assignee: Bayer Aktiengesellschaft
    Inventors: Franz-Josef Mais, Günther Cramm, Alexander Klausener, Guido Steffan
  • Patent number: 6436943
    Abstract: The invention relates to dihydropyrimidines of the general formula and to the use of dihydropyrimidines as medicaments for the treatment and prophylaxis of hepatitis B. The invention further relates to a process for the preparation of medicaments comprising the corresponding dihydropyrimidines.
    Type: Grant
    Filed: October 18, 2000
    Date of Patent: August 20, 2002
    Assignee: Bayer Aktiengesellschaft
    Inventors: Jürgen Stoltefuss, Siegfried Goldmann, Arnold Paessens, Erwin Graef, Stefan Lottmann
  • Patent number: 6432879
    Abstract: The invention relates to novel substituted phenyluracils of the general formula (I) in which the radicals n, Q, R1 to R6 are each as defined in the description, and to processes for this preparation and to their use as herbicides.
    Type: Grant
    Filed: May 23, 2000
    Date of Patent: August 13, 2002
    Assignee: Bayer Aktiengesellschaft
    Inventors: Roland Andree, Mark Wilhelm Drewes, Markus Dollinger, Ingo Wetcholowsky, Randy Allen Myers
  • Patent number: 6432964
    Abstract: The invention provides the use in combating fungi of compounds of general formula (I) wherein R1 is hydrogen, hydroxy, acyl, acyloxy, optionally substituted amino, Ra, Ra3Si, RaS or RaO, where Ra is optionally substituted alkyl, optionally substituted alkenyl, optionally substituted alkynyl, optionally substituted cycloalkyl, optionally substituted cycloalkenyl, optionally substituted aryl or optionally substituted heterocyclyl; R2 has the same meaning as Ra or can be hydrogen; Z is oxygen or sulfur, M is a thiophene ring, and R3 and R4, which may be the same or different, have the same meaning as Ra or can be optionally substituted amino, hydrogen, halogen, cyano, nitro or a group ORc or S(O)mRc, where Rc has the same meaning as Ra or is hydrogen or acyl and m is 0, 1 or 2; or R3 and R4 together with the atoms to which they are attached form an optionally substituted carbocyclic or heterocyclic ring; together with tautomers of compounds where R1 is hydrogen.
    Type: Grant
    Filed: November 5, 1999
    Date of Patent: August 13, 2002
    Assignee: Agrevo UK Limited
    Inventors: John Frederick Atherall, Thomas Lawley Hough, Stephen David Lindell, Mary Josephine O'Mahony, John Henry Parsons, Elizabeth Anne Saville-Stones
  • Patent number: 6433170
    Abstract: The invention relates to a novel method for producing 4-[(2′,5′-diamino-6′-halopyrimidine-4′-yl)amino]-cyclopent-2-enylmethanols of general formula (I), wherein X represents a halogen atom. According to the inventive method amino-4,6-halopyrimidine of general formula (II), wherein X has the aforementioned meaning, is reacted with a 4-aminocyclopent-2-enylmethanol of formula (III) or with a salt thereof in the presence of a base in a polar protic solvent.
    Type: Grant
    Filed: June 17, 2001
    Date of Patent: August 13, 2002
    Assignee: Lonza Group
    Inventors: Walter Brieden, Elie Saikali
  • Patent number: 6420368
    Abstract: The thienopyrimidines of the formula (I) and their physiologically compatible salts display a phosphodiesterase V inhibiting activity and can be used for treating diseases of the cardiovascular system and for treatment and/or therapy of erectile dysfunction.
    Type: Grant
    Filed: May 26, 2000
    Date of Patent: July 16, 2002
    Assignee: Merck Patent Gesellschaft mit beschraenkter Haftung
    Inventors: Rochus Jonas, Pierre Schelling, Franz-Werner Kluxen, Maria Christadler
  • Patent number: 6420313
    Abstract: The invention relates to novel thienylalkylamino-1,3,5-triazines of the general formula (I) in which A, R1, R2, R3, R4, R5 and Z are as defined in the description, to processes for their preparation, to their use as herbicides and to novel intermediates and their preparation.
    Type: Grant
    Filed: November 30, 2000
    Date of Patent: July 16, 2002
    Assignees: Bayer Aktiengesellschaft, Nihon Bayer Agrochem, K.K.
    Inventors: Rolf Kirsten, Hans-Jochem Riebel, Stefan Lehr, Katharina Voigt, Kristian Kather, Mark Wilhelm Drewes, Markus Dollinger, Ingo Wetcholowsky, Yukiyoshi Watanabe, Toshio Goto
  • Patent number: 6417360
    Abstract: The compounds of formula (I) wherein R1 has the significance as given in the description, are inhibitors of endothelin receptors and can therefore be used for the treatment of disorders which are associated with abnormal vascular tone and endothelial dysfunction.
    Type: Grant
    Filed: February 17, 2000
    Date of Patent: July 9, 2002
    Assignee: Hoffmann-La Roche Inc.
    Inventors: Volker Breu, Philippe Coassolo, Werner Neidhart, Sébastien Roux, Peter Weiss
  • Patent number: 6414146
    Abstract: An isocyanurate compound of the formula (1), wherein R is a hydrogen atom or a methyl group, a method for producing said iscyanurate compound, characterized by reacting carbon disulfide with a triglycidyl isocyanurate compound, and a trithiol isocyanurate compound and a method for producing the same.
    Type: Grant
    Filed: January 29, 2002
    Date of Patent: July 2, 2002
    Assignee: Nissan Chemical Industries, Ltd.
    Inventors: Toshiaki Takeyama, Motohiko Hidaka, Kazuhiko Akimoto
  • Patent number: 6413911
    Abstract: Sulfonylureas of the general formula I where R1 is a methyl or ethyl group; R2 is C1-C3-alkoxycarbonyl, a C1-C2-alkyl group which carries 1 to 5 fluorine atoms, methylsulfonyl, dimethylaminosulfonyl, thiomethyl, methylsulfinyl, methylsulfonyloxy, trifluoromethoxy, difluoromethoxy, difluorochloromethoxy, difluorochloromethyl or nitro; R3 is hydrogen, methyl, methoxy, ethoxy, fluorine, chlorine or thiomethyl; W is hydrogen or chlorine and Z is CH or N and their agriculturally utilizable salts are described.
    Type: Grant
    Filed: June 14, 2001
    Date of Patent: July 2, 2002
    Assignee: BASF Aktiengesellschaft
    Inventors: Horst Mayer, Gerhard Hamprecht, Karl-Otto Westphalen, Matthias Gerber, Helmut Walter
  • Patent number: 6410482
    Abstract: (Het)Arylsulfonylureas having an imino function, their preparation, and their use as herbicides and plant growth regulators Compounds of the formula (I) and salts thereof in which A is a (hetero)aromatic or heterocyclic bridge linked to the group SO2 by a direct bond, or via O, S, NH, CH2 or via alkylated NH or alkylated methylene, B is a group having an imino-containing fragment N═C—N, N═C—S, N═C—O or N═C—C which is linked to A by one of the nitrogen atoms of the fragment, R═H or an aliphatic radical, W═O or S and X, Y and Z are as defined in claim 1 are suitable as herbicides and plant growth regulators. The preparation is carried out for example similarly to known processes via novel intermediates of the formula (XII) (cf.
    Type: Grant
    Filed: May 13, 1997
    Date of Patent: June 25, 2002
    Assignee: Hoechst Schering AgrEvo GmbH
    Inventors: Gerhard Schnabel, Lothar Willms, Klaus Bauer, Hermann Bieringer, Christopher Rosinger
  • Patent number: 6410483
    Abstract: Compounds of the formula (I) and salts thereof in which R1-R9, W and A are as defined in formula (I) of claim 1 are suitable as herbicides and plant growth regulators. They can be prepared by processes according to claim 5 via intermediates according to claim 9, some of which are novel.
    Type: Grant
    Filed: January 21, 1998
    Date of Patent: June 25, 2002
    Assignee: Hoechst Schering AgrEvo GmbH
    Inventors: Klaus Lorenz, Lothar Willms, Klaus Bauer, Hermann Bieringer, Christopher Rosinger
  • Patent number: 6407115
    Abstract: Accordingly, an object of this invention is to provide a hexa-cyclic compound represented by the following general formula: wherein R1 and R2 individually represent a hydrogen atom, a hydroxyl group, a C1-6 alkyl group (“C1-6 alkyl group means an alkyl group having 1 to 6 carbon atoms. Hereinafter defined in the same manner.) The present inventors have conducted extensive studies for the purpose of obtaining camptothecin derivatives with more excellent activity and higher safety, as well as excellent characteristics required for a drug to be administered, and found that hexa-cyclic compounds obtained by the addition of a water-soluble ring to camptothecin had characteristics superior to camptothecin. This finding has led to the completion of this invention.
    Type: Grant
    Filed: May 26, 1995
    Date of Patent: June 18, 2002
    Assignees: Daiichi Pharmaceutical Co., Ltd., Kabushiki Kaisha Yakult Honsha
    Inventors: Hirofumi Terasawa, Akio Ejima, Satoru Ohsuki, Kouichi Uoto
  • Patent number: 6407101
    Abstract: This invention provides a progesterone receptor antagonist of formula 1 having the structure wherein T is O, S, or absent; R1, and R2 are each, independently, hydrogen, alkyl, substituted alkyl; or R1 and R2 are taken together form a ring and together contain —CH2(CH2)nCH2—, —CH2CH2CMe2CH2CH2—, —O(CH2)pCH2—, —O(CH2)qO—, —CH2CH2OCH2CH2—, or —CH2CH2NR7CH2CH2—; n=1-5; p=1-4; q=1-4; R3 is hydrogen, OH, NH2, alkyl, substituted alkyl, alkenyl, substituted alkenyl, alkynyl, substituted alkynyl, or CORA; RA is hydrogen, alkyl, substituted alky, alkoxy, substituted alkoxy, aminoalkyl, or substituted aminoalkyl; R4 is hydrogen, halogen, CN, NH2, alkyl, substituted alkyl, alkoxy, substituted alkoxy, aminoalkyl, or substituted aminoalkyl; R5 is hydrogen, allyl, or substituted alkyl; R6 is hydrogen, alkyl, substituted alkyl, or CORB; RB is hydrogen, alkyl, substituted alkyl, alko, substituted alkoxy, amino
    Type: Grant
    Filed: April 19, 2000
    Date of Patent: June 18, 2002
    Assignees: American Home Products Corporation, Ligand Pharmaceuticals, Inc.
    Inventors: Mark A. Collins, Valerie A. Mackner, Jay E. Wrobel, Lin Zhi, Todd K. Jones, James P. Edwards, Christopher M. Tegley
  • Patent number: 6407097
    Abstract: The invention relates to novel methoximinomethyloxathiazines, to two processes for their preparation and to their use as pesticides.
    Type: Grant
    Filed: October 30, 2000
    Date of Patent: June 18, 2002
    Assignee: Bayer Aktiengesellschaft
    Inventors: Herbert Gayer, Peter Gerdes, Ulrich Heinemann, Bernd-Wieland Krüger, Klaus Stenzel
  • Patent number: 6407041
    Abstract: The invention relaters to compounds of the formula: and their use as herbicides.
    Type: Grant
    Filed: July 10, 2000
    Date of Patent: June 18, 2002
    Assignees: Bayer Aktiengesellschaft, Nihon Bayer Agrochem, K.K.
    Inventors: Katharina Voigt, Hans-Jochem Riebel, Stefan Lehr, Andreas Lender, Rolf Kirsten, Markus Dollinger, Mark Wilhelm Drewes, Ingo Wetcholowsky, Yukiyoshi Watanabe, Toshio Goto, Randy Allen Myers
  • Patent number: 6403790
    Abstract: A process for preparing epinastine hydrochloride of formula (I) the process comprising: (a) suspending and dissolving an epinastine base of formula (II)  in water by the addition of aqueous hydrochloric acid at a pH of ≧7; (b) extracting the aqueous solution obtained from step (a) with an organic, water-immiscible solvent; (c) removing the organic, water-immiscible solvent from the aqueous solution obtained from step (b); and (d) adjusting the pH of the aqueous solution of step (c) to ≦6 using hydrochloric acid to precipitate the product of formula (I), and then drying the product.
    Type: Grant
    Filed: November 20, 2000
    Date of Patent: June 11, 2002
    Assignee: Boehringer Ingelheim Pharma KG
    Inventor: Rolf Dach